Thinking Out Loud (Blog)
Six months in, are we any closer to a vaccine?
Are we "Checking the Box" or Making Vaccines that work? We need a COVID-19 vaccine! From China to the US to Europe and even Africa, scientists are working tirelessly, if not at "warp speed", to develop and test more than one COVID-19 vaccine. May global scientific...
read more
Spy Vs Spy and … Making Better B-cell Derived Antibodies for COVID-19
Pepcid: From Poor Man's Cure to $20M COVID-19 Trial Remember Hydrocychloroquine? The drug that doesn't work for COVID-19? Well, here's some good news for you. A crazy rock climber/mountain rescue nut named Michael Callahan and a brilliant group of 3D modelers working...
read more
Press Release: PharmaJet partners with Immunomic Therapeutics and EpiVax to develop and deliver COVID-19 Vaccine
Originally published via PR Newswire GOLDEN, Colo., April 14, 2020 /PRNewswire/ -- PharmaJet®, the maker of innovative, needle-free injection technology, today announced that its Tropis® Needle-free injection system will be used to deliver a COVID-19 vaccine being...
read more
Press Release: Immunomic Therapeutics Forms Collaboration with EpiVax and PharmaJet to Develop Novel Vaccine Candidate Against COVID-19 Using its Investigational UNITE Platform
Read the original BusinessWire publication here. ROCKVILLE, MD, PROVIDENCE, RI, and GOLDEN, CO, April 09, 2020 -- Immunomic Therapeutics, Inc., a privately held clinical stage biotechnology company pioneering the study of nucleic acid immunotherapy platforms,...
read more
Imagining The Future: What Will Life Be Like After #COVID-19?
Through the Futuroscope The COVID-19 crisis has frozen time, and yet, there will be a future beyond COVID. What will life be like in 4 months? 6 months? A year? Can we imagine that future? It's hard, but yes, a new day will come, and progress is inevitable. Remember...
read more
Webinar: Science in the Time of COVID-19
This webinar has passed. You may watch the recorded recap here. We invite you to join us on May 15, 2020 for "Immune Engineering Human B cell-Derived Antibodies for Emerging Infectious Diseases" Please extend this invitation to any colleagues or associates you feel...
read more